Vericel Corp has a consensus price target of $47.6 based on the ratings of 10 analysts. The high is $57 issued by Truist Securities on July 16, 2024. The low is $29 issued by Truist Securities on January 31, 2023. The 3 most-recent analyst ratings were released by Truist Securities, BTIG, and TD Cowen on July 16, 2024, July 15, 2024, and June 20, 2024, respectively. With an average price target of $55.67 between Truist Securities, BTIG, and TD Cowen, there's an implied 6.40% upside for Vericel Corp from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
07/16/2024 | Buy Now | 8.94% | Truist Securities | Samuel Brodovsky | $56 → $57 | Maintains | Buy | Get Alert |
07/15/2024 | Buy Now | 5.12% | BTIG | Ryan Zimmerman | $56 → $55 | Maintains | Buy | Get Alert |
06/20/2024 | Buy Now | 5.12% | TD Cowen | Joshua Jennings | → $55 | Initiates | → Buy | Get Alert |
05/09/2024 | Buy Now | 5.12% | HC Wainwright & Co. | Swayampakula Ramakanth | $53 → $55 | Maintains | Buy | Get Alert |
03/26/2024 | Buy Now | 3.21% | Truist Securities | Samuel Brodovsky | $54 → $54 | Reiterates | Buy → Buy | Get Alert |
03/01/2024 | Buy Now | 3.21% | Truist Securities | Samuel Brodovsky | $51 → $54 | Maintains | Buy | Get Alert |
03/01/2024 | Buy Now | 1.3% | HC Wainwright & Co. | Swayampakula Ramakanth | $46 → $53 | Maintains | Buy | Get Alert |
01/25/2024 | Buy Now | -2.52% | Truist Securities | Samuel Brodovsky | $39 → $51 | Upgrade | Hold → Buy | Get Alert |
01/16/2024 | Buy Now | -12.08% | HC Wainwright & Co. | Swayampakula Ramakanth | $44.5 → $46 | Maintains | Buy | Get Alert |
11/09/2023 | Buy Now | -25.46% | Truist Securities | Samuel Brodovsky | $33 → $39 | Maintains | Hold | Get Alert |
10/16/2023 | Buy Now | -19.72% | Leerink Partners | Mike Kratky | → $42 | Initiates | → Outperform | Get Alert |
09/21/2023 | Buy Now | -25.46% | Truist Securities | Samuel Brodovsky | → $39 | Reiterates | Hold → Hold | Get Alert |
09/21/2023 | Buy Now | -15.9% | Stephens & Co. | George Sellers | → $44 | Reiterates | Overweight → Overweight | Get Alert |
09/21/2023 | Buy Now | -14.95% | HC Wainwright & Co. | Swayampakula Ramakanth | $41 → $44.5 | Maintains | Buy | Get Alert |
08/08/2023 | Buy Now | -25.46% | BTIG | Ryan Zimmerman | → $39 | Upgrade | Neutral → Buy | Get Alert |
08/03/2023 | Buy Now | -25.46% | Truist Securities | Samuel Brodovsky | $42 → $39 | Maintains | Hold | Get Alert |
08/03/2023 | Buy Now | -21.64% | HC Wainwright & Co. | Swayampakula Ramakanth | $37 → $41 | Maintains | Buy | Get Alert |
07/19/2023 | Buy Now | -19.72% | Truist Securities | Samuel Brodovsky | $36 → $42 | Maintains | Hold | Get Alert |
05/11/2023 | Buy Now | -31.19% | Truist Securities | Samuel Brodovsky | $31 → $36 | Maintains | Hold | Get Alert |
05/11/2023 | Buy Now | -19.72% | Stephens & Co. | Chris Cooley | $39 → $42 | Maintains | Overweight | Get Alert |
02/27/2023 | Buy Now | -40.75% | Truist Securities | Samuel Brodovsky | $29 → $31 | Maintains | Hold | Get Alert |
01/31/2023 | Buy Now | -44.57% | Truist Securities | Richard Newitter | $25 → $29 | Maintains | Hold | Get Alert |
01/27/2023 | Buy Now | -29.28% | HC Wainwright & Co. | Swayampakula Ramakanth | → $37 | Reiterates | → Buy | Get Alert |
01/03/2023 | Buy Now | -29.28% | HC Wainwright & Co. | Swayampakula Ramakanth | $35 → $37 | Maintains | Buy | Get Alert |
12/20/2022 | Buy Now | -52.22% | Truist Securities | Samuel Brodovsky | $22 → $25 | Maintains | Hold | Get Alert |
11/10/2022 | Buy Now | -33.1% | HC Wainwright & Co. | Swayampakula Ramakanth | $53 → $35 | Maintains | Buy | Get Alert |
11/10/2022 | Buy Now | — | BTIG | Ryan Zimmerman | — | Downgrade | Buy → Neutral | Get Alert |
07/18/2022 | Buy Now | -35.02% | BTIG | Ryan Zimmerman | $45 → $34 | Maintains | Buy | Get Alert |
02/25/2022 | Buy Now | -13.99% | SVB Leerink | Danielle Antalffy | $40 → $45 | Maintains | Outperform | Get Alert |
12/21/2021 | Buy Now | -0.61% | Truist Securities | Kaila Krum | $55 → $52 | Maintains | Buy | Get Alert |
08/05/2021 | Buy Now | 18.5% | SVB Leerink | Danielle Antalffy | — | Maintains | Outperform | Get Alert |
The latest price target for Vericel (NASDAQ:VCEL) was reported by Truist Securities on July 16, 2024. The analyst firm set a price target for $57.00 expecting VCEL to rise to within 12 months (a possible 8.94% upside). 17 analyst firms have reported ratings in the last year.
The latest analyst rating for Vericel (NASDAQ:VCEL) was provided by Truist Securities, and Vericel maintained their buy rating.
The last upgrade for Vericel Corp happened on January 25, 2024 when Truist Securities raised their price target to $51. Truist Securities previously had a hold for Vericel Corp.
The last downgrade for Vericel Corp happened on November 10, 2022 when BTIG changed their price target from N/A to N/A for Vericel Corp.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Vericel, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Vericel was filed on July 16, 2024 so you should expect the next rating to be made available sometime around July 16, 2025.
While ratings are subjective and will change, the latest Vericel (VCEL) rating was a maintained with a price target of $56.00 to $57.00. The current price Vericel (VCEL) is trading at is $52.32, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.